Author

Puhua Wu

Observed name: Wu, Puhua

Institution: Hubei Polytechnic University

Observed institutions: Shanghai Jiao Tong University, University of Macau, Hubei Polytechnic University, State Key Laboratory of Microbial Metabolism

ORCID: 0000-0001-7860-761X

Observed ORCID: 0000-0001-7860-761X

OpenAlex ID: A5077051300

Convenient and versatile synthesis of formyl-substituted benzoxaboroles

2009 · Long Ye, Dazhong Ding, et al. · Tetrahedron · 37

Recent developments of human monocarboxylate transporter (hMCT) inhibitors as anticancer agents

2021 · Puhua Wu, Yan Zhou, et al. · Drug Discovery Today · 26

Novel pyrrolobenzoxaboroles: Design, synthesis, and biological evaluation against Trypanosoma brucei

2014 · Puhua Wu, Jiong Zhang, et al. · European Journal of Medicinal Chemistry · 24

Dichloroacetophenone biphenylsulfone ethers as anticancer pyruvate dehydrogenase kinase inhibitors in non-small cell lung cancer models

2023 · Yizhen Guo, Yan Zhou, et al. · Chemico-Biological Interactions · 14

Novel Dichloroacetophenone-Based PDHK1 Inhibitors as Potent Anticancer Agents

2024 · Puhua Wu, Zhicheng Zhang, et al. · Drug Design Development and Therapy · 2

Insights into the binding mechanism and structural requirements of LPAR2 antagonists as antifibrotic agents based on homology modeling, molecular docking, prediction of membrane permeability and 3D QSAR

2026 · Ying Zhang, Guifu Xu, et al. · Journal of Computer-Aided Molecular Design

Insights into the binding site and structural requirements of lysophosphatidic acid receptor 2 (LPAR2) antagonists as antifibrotic agents: an in silico study

2025 · Wu, Puhua · Figshare

Works count: 7

Citation count: 103

H-index: 4

I10-index: 4